Skip to Content

Anti-Canakinumab (Human) ELISA Kit

(0 review)
Ref. TRC-00083
Size: 96 Well
Application: Biomarker research in biological samples.
Price
1,290.00 1,290.00
Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days

TRC-00083 | Anti-Canakinumab (Human) ELISA Kit | 96 Well

Product Overview

A sandwich ELISA kit for the qualitative detection of Anti-Canakinumab in Plasma,Serum.

Canakinumab is a recombinant human IgG1 kappa monoclonal antibody that binds to and inhibits human IL-1β by preventing the interaction with its receptor and subsequent inflammatory activity. The antibody neither has cross-reactivity with IL-1α nor with the Interleukin 1 receptor, type I (IL1R1). The antibody has been approved to treat cryopyrin-associated periodic syndromes (CAPS). anti-Canakinumab ELISA kit has been developed to detect antibodies to Canakinumab in human serum or plasma. The kit is based on the sandwich ELISA principle wherein controls and samples (serum or plasma) are added in the microtiter plate coated with Canakinumab. After incubation, the wells are washed and the enzymatic activity is detected by the addition of chromogen-substrate. The enzyme-substrate reaction is terminated with an acidic stop solution. The color developed is proportional to the amount of antibodies specific for Canakinumab present in the samples and controls. The qualitative test results can be evaluated using cut-off value.

Assay Information

Assay FormatSandwich ELISA
Species ReactivityHuman
Sample TypePlasma,Serum
Detection MethodAbsorbance (450 nm)
Detection Wavelength450 nm
Kit Size96 Well

Applications

This ELISA kit is used for qualitative detection of Anti-Canakinumab in Plasma,Serum.

Features & Benefits

  • Designed for qualitative detection of Anti-Canakinumab.
  • Assay format: Sandwich ELISA.
  • Sample type: Plasma,Serum.
  • Detection method: Absorbance (450 nm).
  • Kit size: 96 Well.

Storage & Shipping

Storage+4°C
ShippingGel Pack
Shelf Life12 Months

Product Details

Catalog NumberTRC-00083
Analyte / TargetAnti-Canakinumab